Dual Sourcing to Help Mitigate Risk in the Supply Chain.

Many pharmaceutical and biopharmaceutical companies are looking toward single-source supply partners to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies.

Robotic Sterile Fill-Finish Is Key for Speed to Clinic and Patient Safety.

With focus on more patient-centric delivery forms such as pre-filled syringes, auto-injectors, and more traditional vials, Sterile fill-finish is a mainstay in pharmaceutical manufacturing, and robotic platforms will be a true differentiator.

EU regulation 536/2014: Key Considerations When Planning for the Return and Destruction of Your Product.

Since the transition period for EU regulation 536/2014 started this year, the focus has returned to meeting all of the demands that will change from the Directive that everyone has been accustomed to following.

Packaging of Biologics and Specialty Medicines: Planning for a Seamless Transition from Clinic to Launch.

Discover how planning for commercial launch requirements earlier in the clinical development cycle may reduce risk-to-launch timelines and avoid unnecessary delays.

Optimizing Your Clinical Trial to Commercialization Journey

What if you could eliminate avoidable delays and have a seamless transition from clinical trials to commercialization when launching your new drug?

The challenges of handling and delivering highly potent oncology drugs

As the R&D in oncological therapies continues to grow, so does demand for the specialist manufacturing, packaging and distribution of such products whether they contain highly potent actives or are biological in nature.

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.